Our work identified miR-21a-5p as a potential regulator of aerobic exercise affecting lipid metabolism, achieved the favorable goal in hyperlipidemia by synergistically inhibiting the expression of target genes FABP7, HMGCR, ACAT1, and OLR1. The gene discussed is FABP7; the disease is hyperlipidemia.